{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:48Z","timestamp":1791304428913,"version":"4.3.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI113048"],"award-info":[{"award-number":["U19 AI113048"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K24 HD062645"],"award-info":[{"award-number":["K24 HD062645"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197269","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T13:33:25Z","timestamp":1526304805000},"page":"e0197269","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-1212","authenticated-orcid":true,"given":"Kate M.","family":"Guthrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle K.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2934-4766","authenticated-orcid":true,"given":"Sara E.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Getz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime J.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-5649","authenticated-orcid":true,"given":"Marc M.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-9551","authenticated-orcid":true,"given":"Kathleen L.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Number of women living with HIV2017 June 14, 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/gho\/hiv\/epidemic_status\/cases_adults_women_children_text\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/gho\/hiv\/epidemic_status\/cases_adults_women_children_text\/en\/<\/ext-link>."},{"key":"ref2","unstructured":"UN Women. Facts and figures: HIV and AIDS 2016 June 14, 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unwomen.org\/en\/what-we-do\/hiv-and-aids\/facts-and-figures\" xlink:type=\"simple\">http:\/\/www.unwomen.org\/en\/what-we-do\/hiv-and-aids\/facts-and-figures<\/ext-link>."},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention. HIV Among Women2017 June 14, 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/hiv\/group\/gender\/women\/\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/hiv\/group\/gender\/women\/<\/ext-link>."},{"key":"ref4","article-title":"Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women","author":"JM Baeten","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"e0157742","DOI":"10.1371\/journal.pone.0157742","article-title":"Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting","volume":"11","author":"MC Montgomery","year":"2016","journal-title":"PLoS One"},{"issue":"22","key":"ref6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women","volume":"375","author":"A Nel","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.contraception.2015.08.007","article-title":"Meaning-making matters in product design: users&apos; sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings","volume":"92","author":"RK Rosen","year":"2015","journal-title":"Contraception"},{"issue":"10\u201311","key":"ref8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1089\/aid.2015.0275","article-title":"Perceptibility and the &quot;Choice Experience&quot;: User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design","volume":"32","author":"KM Guthrie","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"e0145642","DOI":"10.1371\/journal.pone.0145642","article-title":"The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development","volume":"10","author":"K Morrow Guthrie","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/aid.2013.0099","article-title":"Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties","volume":"30","author":"KM Morrow","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s10461-007-9266-z","article-title":"Assessing microbicide acceptability: a comprehensive and integrated approach","volume":"12","author":"KM Morrow","year":"2008","journal-title":"AIDS Behav"},{"key":"ref12","unstructured":"Clinicaltrials.gov. Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy Women 2014 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02431273\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02431273<\/ext-link>."},{"key":"ref13","first-page":"221","article-title":"Drug Delivery and Development of Anti-HIV Microbicides","author":"JA Moss","year":"2015"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijpharm.2015.09.028","article-title":"An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate","volume":"495","author":"MM Baum","year":"2015","journal-title":"Intl J Pharm"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/jps.23208","article-title":"An intravaginal ring for the simultaneous delivery of multiple drugs","volume":"101","author":"MM Baum","year":"2012","journal-title":"J Pharm Sci"},{"key":"ref16","author":"G Guest","year":"2011"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"NK Gale","year":"2013","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/nr2011.01.18.2.52.c8284","article-title":"Qualitative data analysis: the framework approach","volume":"18","author":"J Smith","year":"2011","journal-title":"Nurse Res"},{"key":"ref19","first-page":"173","article-title":"Analyzing Qualitative Data","author":"J Ritchie","year":"1994"},{"key":"ref20","article-title":"NVivo qualitative data analysis Software. Version 10","year":"2012"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/acem.12692","article-title":"Patient Engagement and the Design of Digital Health","volume":"22","author":"F Birnbaum","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/1049732317697947","article-title":"\u201cLike Holding an Umbrella Before It Rains\u201d: Acceptability of Future Rectal Microbicides Among Men Who Have Sex With Men in India\u2014A Modified Technology Acceptance Model","volume":"27","author":"V Chakrapani","year":"2017","journal-title":"Qual Health Res"},{"issue":"10","key":"ref23","article-title":"Measuring self-efficacy to use vaginal microbicides: the Microbicide Use Self-Efficacy instrument","volume":"28","author":"JL Fava","year":"2013","journal-title":"Sex Health"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s10461-013-0652-4","article-title":"&quot;Set it and forget it&quot;: Women&apos;s perceptions and opinions of long-acting topical vaginal gels","volume":"18","author":"JJ van den Berg","year":"2014","journal-title":"AIDS Behav"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10837450.2017.1339085","article-title":"Vaginal Film for Prevention of HIV: Using Visual and Tactile Evaluations among Potential Users to Inform Product Design","volume":"23","author":"KM Guthrie","year":"2018","journal-title":"Pharm Dev Technol"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s13346-017-0397-0","article-title":"User Input in Iterative Design for Prevention Product Development: Leveraging Interdisciplinary Methods to Optimize Effectiveness","volume":"7","author":"KM Guthrie","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"ref27","first-page":"1","article-title":"On-demand microbicide products: design matters","author":"SK Patel","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"ref28","unstructured":"AVAC: Global Advocacy for HIV Prevention. ARV-Based Prevention Pipeline 2016 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.avac.org\/infographic\/arv-based-prevention-pipeline\" xlink:type=\"simple\">http:\/\/www.avac.org\/infographic\/arv-based-prevention-pipeline<\/ext-link>."},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy","volume":"71","author":"R Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet","volume":"8","author":"E Weisberg","year":"2005","journal-title":"Climacteric"},{"issue":"7","key":"ref31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10508-013-0235-5","article-title":"User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides","volume":"43","author":"KM Morrow","year":"2014","journal-title":"Arch Sex Behav"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jwh.2006.0325","article-title":"Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study","volume":"17","author":"RK Rosen","year":"2008","journal-title":"J Womens Health (Larchmt)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:55:23Z","timestamp":1540032923000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197269"}},"subtitle":[],"editor":[{"given":"Godfrey B.","family":"Woelk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197269","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]}}}